Ergoteles’s Prothena Corp PRTA Stock Holding History

Ergoteles’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,276	Closed	-$906K	–	641
2023 Q2	$906K	Sell	13,276 -13,635	-51%	-$879K	0.04%	491
2023 Q1	$1.3M	Buy	26,911 +11,386	+73%	+$602K	0.05%	397
2022 Q4	$935K	Buy	15,525 +11,722	+308%	+$686K	0.03%	480
2022 Q3	$231K	Buy	+3,803	New	+$120K	0.01%	1103
2022 Q1	–	Sell	-8,800	Closed	-$435K	–	1560
2021 Q4	$435K	Buy	+8,800	New	+$488K	0.02%	695

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ergoteles's PRTA Position: Q3 2023 in Review

Ergoteles sold out of Prothena Corp (PRTA) in Q3 2023, closing a stake of 13,276 shares — an estimated $906K sold.

Ergoteles first reported a position in PRTA in Q4 2021 and held it in 5 quarters. The position peaked at $1.3M in Q1 2023. 186 funds tracked by Wall St. Rank hold PRTA as of Q3 2023.

Ergoteles reported no remaining Prothena Corp position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 13,276 Prothena Corp shares in Q3 2023, an estimated $906K.
Ergoteles first reported a position in Prothena Corp in Q4 2021 and held it in 5 quarters.
Ergoteles's Prothena Corp position peaked at $1.3M in Q1 2023.
186 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.